777TiP Phase I study of LYL797, a ROR1-targeted CAR T-cell therapy with genetic and epigenetic reprogramming for the treatment of advanced solid tumors
| Autor: | Spigel, D.R., Murthy, H., Chumsri, S., Ganguly, B.J., Gong, L., Hiraragi, H., Larsen, E., Liu, W., Martell, L., Zhu, S., Bornman, I-M., Fitzsimmons, S., Barnum, E., Christiansen, S., Gillenwater, H. |
|---|---|
| Zdroj: | In Annals of Oncology September 2022 33 Supplement 7:S896-S896 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|